Trandolapril and Verapamil Hydrochloride
4 mg/1 / 240 mg/1 · Tablet Film Coated Extended Release
By Glenmark Pharmaceuticals Inc., USA
- NDC
- 68462-329
- Route
- Oral
- Therapeutic class
- Angiotensin Converting Enzyme Inhibitor , Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker , Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- Marketing category
- ANDA
Package sizes
- 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-329-01)NDC 68462-329-01Available to order
- 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-329-10)NDC 68462-329-10Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Cardiovascular
See all →
Multivitamin with Fluoride
15 [iU]/1 / 60 mg/1 +9 · Tablet Chewable
Method Pharmaceuticals, LLC
Available to source
Multivitamin with Fluoride
15 [iU]/1 / 60 mg/1 +9 · Tablet Chewable
Method Pharmaceuticals, LLC
Available to source
Multivitamin with Fluoride
15 [iU]/1 / 60 mg/1 +9 · Tablet Chewable
Bryant Ranch Prepack
Available to source
Multivitamin with Fluoride
15 [iU]/1 / 60 mg/1 +9 · Tablet Chewable
Bryant Ranch Prepack
Available to source